Eleonora Dimitrova
Eleonora Dimitrova
Verified email at mu-varna.bg
Title
Cited by
Cited by
Year
Association between serum CK-18 levels and the degree of liver damage in fructose-induced metabolic syndrome
K Bratoeva, S Nikolova, A Merdzhanova, GS Stoyanov, E Dimitrova, ...
Metabolic Syndrome and Related Disorders 16 (7), 350-357, 2018
32018
RIPK3 expression as a potential predictive and prognostic marker in metastatic colon cancer
NV Conev, EG Dimitrova, MK Bogdanova, YK Kashlov, BG Chaushev, ...
Clinical and Investigative Medicine 42 (1), E31-E38, 2019
22019
Role of the pretreatment 18F-fluorodeoxyglucose positron emission tomography maximal standardized uptake value in predicting outcomes of colon liver metastases and that value's …
EG Dimitrova, BG Chaushev, NV Conev, JK Kashlov, AK Zlatarov, ...
BioScience Trends, 2016.01205, 2017
22017
Time perception as a novel ultra-short screening tool for distress in cancer patients.
NV Conev, I Donev, D Stoyanov, M Ivanova, E Dimitrova, A Yanchev
Journal of Clinical Oncology 36 (15_suppl), e22123-e22123, 2018
12018
High neutrophil to lymphocyte ratio as a predictor for hyperprogressive disease in patients with metastatic non-small cell lung cancer treated with pembrolizumab as a second line.
M Petrova, M Eneva, JI Arabadjiev, NV Conev, E Dimitrova, KD Koynov, ...
Journal of Clinical Oncology 38 (15_suppl), e21546-e21546, 2020
2020
Dynamic of time estimation and its relation with levels of distress.
NV Conev, M Ivanova, E Dimitrova, A Yanchev, I Donev
Journal of Clinical Oncology 38 (15_suppl), e19091-e19091, 2020
2020
Gender and time estimation as novel potent indicators of emotional concerns in cancer patients.
A Yanchev, M Ivanova, I Donev, E Dimitrova, NV Conev
Journal of Clinical Oncology 38 (15_suppl), e24195-e24195, 2020
2020
Sarcopenia as a negative predictive marker for treatment with pembrolizumab as a second line in patients with metastatic non-small cell lung cancer.
M Petrova, G Valchev, NV Conev, E Dimitrova, B Robev, M Boneva, ...
Journal of Clinical Oncology 38 (15_suppl), e21541-e21541, 2020
2020
Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer
MP Petrova, MI Eneva, JI Arabadjiev, NV Conev, EG Dimitrova, ...
BioScience Trends 14 (1), 48-55, 2020
2020
Expression of hepatic HMGB1 levels in fructose-induced fatty liver
K Bratoeva, E Dimitrova, N Conev, J Kashlov, E Panajotova, G Stoyanov, ...
Varna Medical Forum 7 (1), 34-40, 2018
2018
Neurotoxicity of cancer agents
N Conev, I Shterev, R Manev, E Dimitrova, D Stoyanov, Y Kashlov, ...
Varna Medical Forum 7 (1), 27-33, 2018
2018
Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies
G Todorov, C Bachvarov, G Valchev, N Kolev, A Tonev, V Ignatov, ...
Varna Medical Forum 7 (1), 11-14, 2018
2018
Minimally invasive ablative techniques of liver tumors
G Todorov, C Bachvarov, G Valchev, N Kolev, A Tonev, V Ignatov, ...
Varna Medical Forum 7 (1), 7-10, 2018
2018
Regulation of cell death in cancer diseases-importance and therapeutic effect
K Bratoeva, E Dimitrova, N Conev, G Todorov, K Kalchev, M Radanova, ...
Varna Medical Forum 6 (2), 47-53, 2017
2017
Expression of Beclin-1 as a Marker for Autophagy and Its Predictive and Prognostic Performance in Patients with Metastatic Colon Cancer
E Dimitrova
PQDT-Global, 2017
2017
Expression of Beclin-1 as a Marker for Autophagy and Its Predictive and Prognostic Performance in Patients with Metastatic Colon Cancer///Експресията на Beclin 1 като маркер за …
E Dimitrova
Medical University of Varna, 2017
2017
FIRST LINE 5-FU-BASED CHEMOTHERAPY WITH/WITHOUT BEVACIZUMAB FOR METASTATIC COLORECTAL CANCER: TISSUE BIOMARKER CANDIDATES
A Konsoulova, I Donev, N Conev, S Draganova, N Petrova, E Dimitrova, ...
Journal of IMAB–Annual Proceeding Scientific Papers 22 (1), 1039-1044, 2016
2016
Автофагия при солидни тумори
НЦ Елеонора Димитрова,Иван Щерев
Парадигма, 2016
2016
First line 5-FU-based chemotherapy with/without bevacizumab for metastatic colorectal cancer: one center experience results
A Konsoulova, I Donev, N Conev, S Draganova, T Chervenkov, N Petrova, ...
Scripta Scientifica Medica 47, 20-25, 2015
2015
2-year single center clinical experience in patients with colon cancer stage II and III receiving adjuvant chemotherapy
NV Conev, IS Donev, E Dimitrova, M Kozhuharova, M Georgieva, ...
Scripta Scientifica Medica 47 (2), 43-48, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–20